NRAS and acute myeloid leukemia: Although the frequency of RAS mutations in MDS is much lower than that in CMML or AML, mutations of RAS in MDS patients, in particular N-RAS, have been found associated with shorter survival and higher risk of transformation into AML [33,34,35].